Charles Carroll Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,615
Closed -$3.05M 40
2023
Q1
$3.05M Hold
12,615
4.67% 9
2022
Q4
$3.31M Buy
12,615
+50
+0.4% +$13.4K 5.12% 10
2022
Q3
$2.83M Buy
12,565
+2,125
+20% +$515K 4.57% 10
2022
Q2
$2.54M Buy
10,440
+4,015
+62% +$984K 3.32% 10
2022
Q1
$1.55M Buy
+6,425
New +$1.48M 1.61% 18

Other funds holding AMGN

Charles Carroll Financial Partners's AMGN Position: Q2 2023 in Review

Charles Carroll Financial Partners sold out of Amgen (AMGN) in Q2 2023, closing a stake of 12,615 shares — an estimated $3.05M sold.

Charles Carroll Financial Partners first reported a position in AMGN in Q1 2022 and held it in 5 quarters. The position peaked at $3.31M in Q4 2022. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Charles Carroll Financial Partners reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Charles Carroll Financial Partners sold 12,615 Amgen shares in Q2 2023, an estimated $3.05M.
  • Charles Carroll Financial Partners first reported a position in Amgen in Q1 2022 and held it in 5 quarters.
  • Charles Carroll Financial Partners's Amgen position peaked at $3.31M in Q4 2022.
  • 2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Charles Carroll Financial Partners's 13F filing for Q2 2023, filed 14 Aug 2023.